Heidi Rehm, PhD, FACMG
"In truth, personalized medicine is what physicians have always practiced. You take the patients' symptoms and their test results and then figure out the best plan for them as an individual. However, we're in a different era now because we can add genetics to the evaluation. We can now stratify populations and decide what the best treatments are for individuals based on their genetic makeup. And most importantly, genetics allows us to be in a much better position to predict the onset of disease, long before there is clinical evidence. This allows a much better opportunity to intervene and prevent adverse outcomes. It’s an exciting time in medicine to focus on prevention." - Heidi Rehm
Heidi Rehm is the Director of the Laboratory for Molecular Medicine at Partners Healthcare Personalized Medicine and Associate Professor of Pathology at Harvard Medical School. Her lab focuses on the translation of new genetic discoveries and technologies into clinical tests that can be used to improve patient outcomes, supporting the model of personalized medicine. She also conducts research in hearing loss, Usher syndrome, genomic medicine, and healthcare IT.